Tumor Markers
Reliable and accessible tumor marker testing plays a crucial role in modern oncology. Our portfolio provides convenient, cost-effective rapid tests designed to support clinical workflows, from initial screening of high-risk populations to the longitudinal monitoring of treatment response. Each test is engineered to provide a consistent and accurate data point, empowering confident patient management.
Prostate Specific Antigen (PSA) Test
A rapid test for the qualitative detection of PSA in whole blood, serum, or plasma.
Powered by NomoFlow™
Alpha-Fetoprotein (AFP) Test
Aids in the management of patients with nonseminomatous testicular cancers.
Powered by NomoFlow™
Fecal Occult Blood (FOB) Test
An essential screening tool for the early detection of colorectal cancer.
Powered by NomoFlow™
The Basis for Confident Clinical Decisions
Consistency for Confident Monitoring
When tracking patient trends, test consistency is non-negotiable. Our NomoFlow™ platform minimizes batch-to-batch variability, ensuring that any observed change in marker levels is due to the patient's clinical status, not test fluctuation.
Broad Clinical Utility
Our portfolio includes key markers for both initial screening and ongoing monitoring. From the widely used FOB test to specific markers like PSA, our tests are designed to integrate seamlessly into established clinical pathways.
Evidence-Based Performance
We believe trust is built on transparency. Comprehensive performance data, including clinical sensitivity and specificity, are readily available, providing the evidence you need to incorporate our tests into your practice with confidence.
Integrate Reliable Marker Testing into Your Practice.
Contact our specialists to learn more about our oncology portfolio, request performance data, or discuss distribution opportunities.